Copy number variation of c-c chemokine ligand 3-like 1 (CCL3L1), c-c chemokine receptor type 5 (CCR5) and CCR2 polymorphisms on the outcomes of antiretroviral therapy among Malaysian HIV patients
HIV/AIDS is a significant burden in Malaysia, affecting more than 90, 000 of the population. Several host genetic variations have been implicated in the pathogenesis of HIV infection, particularly on HIV susceptibility and disease progression to AIDS. These include CCR5 and CCL3L1,...
Main Author: | Mohamad Isa, Irma Izani |
---|---|
Format: | Thesis |
Language: | English |
Published: |
2020
|
Subjects: | |
Online Access: | http://psasir.upm.edu.my/id/eprint/90061/1/FPSK%28p%29%202020%201%20-%20IR.pdf |
Similar Items
-
Systematic Assessment of Chemokine Signaling at Chemokine Receptors CCR4, CCR7 and CCR10
by: Herman D. Lim, et al.
Published: (2021-04-01) -
Chemokine Ligand 5 (CCL5) and chemokine receptor (CCR5) genetic variants and prostate cancer risk among men of African Descent: a case-control study
by: Kidd LaCreis R, et al.
Published: (2012-11-01) -
Functional expression of CCL8 and its interaction with chemokine receptor CCR3
by: Baosheng Ge, et al.
Published: (2017-12-01) -
CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of the Ligands of Receptors CCR1, CCR2, CCR3, and CCR4
by: Jan Korbecki, et al.
Published: (2020-11-01) -
CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of Receptors CCR5, CCR6, CCR7, CCR8, CCR9, and CCR10 Ligands
by: Jan Korbecki, et al.
Published: (2020-10-01)